S&P 500   4,202.09 (-0.08%)
DOW   32,970.07 (-0.37%)
QQQ   349.61 (+0.35%)
AAPL   177.06 (+0.93%)
MSFT   331.38 (-0.45%)
META   263.28 (+0.47%)
GOOGL   123.15 (-1.17%)
AMZN   121.18 (+0.89%)
TSLA   198.73 (+2.88%)
NVDA   400.69 (+2.88%)
NIO   7.38 (-4.16%)
BABA   78.31 (-3.29%)
AMD   125.72 (-1.03%)
T   15.62 (+0.77%)
F   12.62 (+4.38%)
MU   72.32 (-2.18%)
CGC   0.87 (-1.01%)
GE   102.08 (-0.64%)
DIS   87.26 (-1.17%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.38 (+1.93%)
NFLX   392.00 (+3.46%)
S&P 500   4,202.09 (-0.08%)
DOW   32,970.07 (-0.37%)
QQQ   349.61 (+0.35%)
AAPL   177.06 (+0.93%)
MSFT   331.38 (-0.45%)
META   263.28 (+0.47%)
GOOGL   123.15 (-1.17%)
AMZN   121.18 (+0.89%)
TSLA   198.73 (+2.88%)
NVDA   400.69 (+2.88%)
NIO   7.38 (-4.16%)
BABA   78.31 (-3.29%)
AMD   125.72 (-1.03%)
T   15.62 (+0.77%)
F   12.62 (+4.38%)
MU   72.32 (-2.18%)
CGC   0.87 (-1.01%)
GE   102.08 (-0.64%)
DIS   87.26 (-1.17%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.38 (+1.93%)
NFLX   392.00 (+3.46%)
S&P 500   4,202.09 (-0.08%)
DOW   32,970.07 (-0.37%)
QQQ   349.61 (+0.35%)
AAPL   177.06 (+0.93%)
MSFT   331.38 (-0.45%)
META   263.28 (+0.47%)
GOOGL   123.15 (-1.17%)
AMZN   121.18 (+0.89%)
TSLA   198.73 (+2.88%)
NVDA   400.69 (+2.88%)
NIO   7.38 (-4.16%)
BABA   78.31 (-3.29%)
AMD   125.72 (-1.03%)
T   15.62 (+0.77%)
F   12.62 (+4.38%)
MU   72.32 (-2.18%)
CGC   0.87 (-1.01%)
GE   102.08 (-0.64%)
DIS   87.26 (-1.17%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.38 (+1.93%)
NFLX   392.00 (+3.46%)
S&P 500   4,202.09 (-0.08%)
DOW   32,970.07 (-0.37%)
QQQ   349.61 (+0.35%)
AAPL   177.06 (+0.93%)
MSFT   331.38 (-0.45%)
META   263.28 (+0.47%)
GOOGL   123.15 (-1.17%)
AMZN   121.18 (+0.89%)
TSLA   198.73 (+2.88%)
NVDA   400.69 (+2.88%)
NIO   7.38 (-4.16%)
BABA   78.31 (-3.29%)
AMD   125.72 (-1.03%)
T   15.62 (+0.77%)
F   12.62 (+4.38%)
MU   72.32 (-2.18%)
CGC   0.87 (-1.01%)
GE   102.08 (-0.64%)
DIS   87.26 (-1.17%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.38 (+1.93%)
NFLX   392.00 (+3.46%)
CVE:PDP

Pediapharm (PDP) Stock Forecast, Price & News

C$0.30
+0.01 (+1.69%)
(As of 12/18/2018)
Compare
Today's Range
C$0.29
▼
C$0.31
50-Day Range
C$0.30
▼
C$0.30
52-Week Range
C$0.25
▼
C$0.49
Volume
26,000 shs
Average Volume
100,369 shs
Market Capitalization
C$66.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsInsider TradesHeadlinesOptions Chain

PDP stock logo

About Pediapharm (CVE:PDP) Stock

Pediapharm Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.

Receive PDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediapharm and its competitors with MarketBeat's FREE daily newsletter.

PDP Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive PDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediapharm and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
CVE:PDP
CUSIP
N/A
CIK
N/A
Web
www.pedia-pharm.com
Phone
+1-514-7622626
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
30.00
P/E Growth
150
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
186.87
Current Ratio
1.12
Quick Ratio
0.71

Sales & Book Value

Annual Sales
C$11.16 million
Price / Sales
5.95
Cash Flow
C$0.01 per share
Price / Cash Flow
23.08
Book Value
C($0.01) per share
Price / Book
-23.08

Miscellaneous

Outstanding Shares
221,194,000
Free Float
N/A
Market Cap
C$66.36 million
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Sylvain Chretien (Age 54)
    Pres, CEO & Director
  • Mr. Roland Boivin
    Chief Financial Officer
  • Mr. Richard Labelle
    VP of Sales & Marketing
  • Mr. Benoît Hébert (Age 50)
    VP of Bus. Devel. & Licensing
  • Mr. Normand Chartrand (Age 59)
    Consultant

Key Competitors

View All Competitors













PDP Stock - Frequently Asked Questions

How have PDP shares performed in 2023?

Pediapharm's stock was trading at C$0.30 at the beginning of the year. Since then, PDP shares have increased by 0.0% and is now trading at C$0.30.
View the best growth stocks for 2023 here.

Is Pediapharm a good dividend stock?

Pediapharm (CVE:PDP) pays an annual dividend of C$0.14 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of Pediapharm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pediapharm investors own include eMagin (EMAN), Eleven Biotherapeutics (EBIO), Coro Mining (COP), Champion Iron (CIA), Anavex Life Sciences (AVXL), AVEO Pharmaceuticals (AVEO), Asterias Biotherapeutics (AST) and Apellis Pharmaceuticals (APLS).

What is Pediapharm's stock symbol?

Pediapharm trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PDP."

How do I buy shares of Pediapharm?

Shares of PDP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Pediapharm's stock price today?

One share of PDP stock can currently be purchased for approximately C$0.30.

How much money does Pediapharm make?

Pediapharm (CVE:PDP) has a market capitalization of C$66.36 million and generates C$11.16 million in revenue each year.

How can I contact Pediapharm?

Pediapharm's mailing address is 1 du Commerce Pl Suite 225, VERDUN, QC H3E 1A2, Canada. The official website for the company is www.pedia-pharm.com. The company can be reached via phone at +1-514-7622626.

This page (CVE:PDP) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -